石榴云医（POM）今日在纳斯达克挂牌上市，股价表现亮眼，盘中大涨12.50%，引发市场广泛关注。
据悉，石榴云医此次IPO发行价为4美元/股，市值约4.74亿美元。作为中国最大的慢病复诊平台，石榴云医成立于2010年，业务涵盖线下药房、医药电商、医药配送和互联网医疗等多个领域，其核心业务为慢病复诊服务。
值得注意的是，石榴云医在上市前已完成九轮融资，投资方阵容强大，包括步长制药、分众传媒、京东集团、中科招商、红杉资本和高特佳投资等知名企业和机构。此次成功登陆纳斯达克，不仅标志着石榴云医进入了新的发展阶段，也反映出资本市场对中国数字健康医疗行业的青睐。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.